About Eugene Williams
Eugene Williams is CEO and director at Autoimmunity Biologic Solutions.
Eugene Williams reports to the SEC as a director or officer of 1 public company: ProMIS Neurosciences (PMN).
Eugene Williams first appears on SEC filings in 2022.
Experience
This experience comes from Eugene Williams's profile and from SEC filings. For roles taken from filings, the years are when the filings name Eugene Williams in the role, so the role may have started earlier or lasted longer.
Autoimmunity Biologic Solutions Inc. Current
CEO and director
2024 – Present · Houston, TX
Develops antibody treatment for people with autoimmune diseases who respond poorly to standard care.
PI
ProMIS™ Neurosciences, Inc. Current
Chairman and Co-Founder
2015 – Present
PI
ProMIS Neurosciences Inc.
Chairman and CEO
2022 – 2026 · Public company (PMN)
MA
Muscular Dystrophy Association
Board Member
2018 – 2022
AI
Akashi Therapeutics, Inc.
Chairman and CEO
2010 – 2014
RL
Red Sky Partners, LLC.
Advisor
2009 – 2011
GE
Genzyme
SVP
1998 – 2006
CD
Corporate Decisions
Partner
1987 – 1995
FB
First Boston
Associate
1986
BC
Bain & Company
Associate
1982 – 1983
Key Colleagues at Startups
The people Eugene Williams works with at each company, as listed on that company's latest Form D.
Autoimmunity Biologic Solutions Inc. · Form D/A, May 6, 2026
JL
Jimmy Lu
Board Director
Brock Reeve
Board Chairman
GM
Gaddiel Galarza-Munoz
Co-founder and CSO
Mariano Garcia-Blanco
Co-founder and Board Director